申请人:Belley Michel
公开号:US20090099226A1
公开(公告)日:2009-04-16
The invention is directed to quinoline derivatives as prostaglandin E type receptor antagonists useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis and cancer. The derivatives have the following structure of formula (I): wherein A and B represents either a nitrogen atom or a CH group with the proviso that they cannot both simultaneously be CH, Q can represent a nitrogen or a carbon atom, and Y and Z are either a nitrogen atom, a N(O) group or a C(R
5
) group. Pharmaceutical compositions comprising the derivatives of formula (I) are also included.
本发明涉及喹啉衍生物作为前列腺素E类型受体拮抗剂,用于治疗EP4介导的疾病或症状,如急性和慢性疼痛、骨关节炎、类风湿性关节炎和癌症。这些衍生物具有以下结构式(I):其中A和B表示氮原子或CH基团,但不能同时为CH,Q可以表示氮原子或碳原子,Y和Z可以是氮原子、N(O)基团或C(R5)基团。还包括含有式(I)的衍生物的制药组合物。